Sigma-Aldrich Corp.

NAS : SIAL
Pharmaceuticals
St. Louis MO
Revenue (US$ Millions)$2,785
Revenue Growth (%)3.00%
Net Income (Millions)$500
Common Shares Outstanding (Millions)$119
Earnings per Share$4.17
Price To Earnings Ratio32.68
Total Equity (Millions)$3,130
Profit Margin 117.95%
Return on Equity17.27%
Long Term Debt (US$ Millions)$300
Debt To Equity Ratio (%)0.10%
Market Capitalization (US$ Millions)$16,335
Total Assets (US$ Millions)$4,195
Return on Assets (%)13.14
Current Assets (US$ Millions)$2,247
Inventories (US$ Millions)$699
Current Liabilities (US$ Millions)$490
Cost of Goods Sold (US$ Millions)$1,366
Asset Turnover0.66
Inventory Turnover1.95